Rating History for Xilio Therapeutics Inc (XLO) by Raymond James

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/21/2026 Sean McCutcheon New Coverage Outperform
(N/A)
16.00
(N/A)
8.54
(7.71)
-9.72% Details